COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS
- Application ID: EP13753904
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). AstraZeneca AB and Grund Intellectual Property Group are specialized in A61. Grund Intellectual Property Group, AstraZeneca AB is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.